Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to compare postoperative immune function (e.g. NK cell activity) of fentanyl-based analgesic regimen versus local anesthetic wound infiltration-based anlagesic regimen after laparoscopic colorectal surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2013
CompletedFirst Posted
Study publicly available on registry
December 16, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJanuary 12, 2016
January 1, 2016
11 months
December 7, 2013
January 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
NK cell activity
NK cell activity : preoperation, POD 1, POD 2
48 hours
IL-2
IL-2 level : preoperation, POD 1, POD 2
48 hours
Secondary Outcomes (1)
Complication and recurrence
1 year
Other Outcomes (1)
Inflammatory responses
48 hours
Study Arms (2)
fentanyl-based analgesia
EXPERIMENTALfentanyl intravenous patient-controlled analgesia + additional pethidine
local anesthetic wound infiltration-based anlagesia
EXPERIMENTALcontinuous wound inflitration with ropivacaine + tramadol intravenous patient-controlled analgesia + additional ketorolac or propacetamol
Interventions
fentanyl based patient-controlled analgesia + additional pethidine for postoperative 48 hour
continuous wound inflitration with ropivacaine + tramadol patient-controlled analgesia + additional ketorolac or propacetamol for postoperative 48 hour
Eligibility Criteria
You may qualify if:
- ASA class I-III
- years old
- elective laparoscopic colorectal surgery for cancer
You may not qualify if:
- drug allergy
- significant renal or hepatic impairment
- sign of infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine
Sedoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
December 7, 2013
First Posted
December 16, 2013
Study Start
January 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2015
Last Updated
January 12, 2016
Record last verified: 2016-01